Active substance
Results for the substance doravirine+lamivudine+tenofovir disoproxil
1 result
About this active substance
The combination of doravirine, lamivudine, and tenofovir disoproxil is used to treat HIV-1 infection in adult patients. This is a combination antiretroviral therapy that works by inhibiting the enzymes necessary for HIV replication.
The medication is taken orally, usually once daily, and is intended for patients who are antiretroviral-naive or have a controlled viral load.
Side effects may include nausea, diarrhea, headaches, or fatigue. In rare cases, severe adverse effects such as kidney or liver dysfunction may occur.
Patients should strictly adhere to the treatment regimen prescribed by their doctor and undergo regular check-ups to monitor the effectiveness and safety of the treatment. Pregnant or breastfeeding women should consult a specialist before use.
The medication is taken orally, usually once daily, and is intended for patients who are antiretroviral-naive or have a controlled viral load.
Side effects may include nausea, diarrhea, headaches, or fatigue. In rare cases, severe adverse effects such as kidney or liver dysfunction may occur.
Patients should strictly adhere to the treatment regimen prescribed by their doctor and undergo regular check-ups to monitor the effectiveness and safety of the treatment. Pregnant or breastfeeding women should consult a specialist before use.